Exact Mass: 195.1623
Exact Mass Matches: 195.1623
Found 191 metabolites which its exact mass value is equals to given mass value 195.1623,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,5-Dibutyl-4-methyloxazole
2,5-Dibutyl-4-methyloxazole is found in cocoa and cocoa products. 2,5-Dibutyl-4-methyloxazole is a constituent of cocoa butter. Constituent of cocoa butter. 2,5-Dibutyl-4-methyloxazole is found in cocoa and cocoa products.
5-Ethyl-2-hexyl-4-methyloxazole
5-Ethyl-2-hexyl-4-methyloxazole is found in potato. 5-Ethyl-2-hexyl-4-methyloxazole is a volatile constituent of French fried potato. Volatile constituent of French fried potato. 5-Ethyl-2-hexyl-4-methyloxazole is found in potato.
4-Methyl-2-pentyl-5-propyloxazole
Not reported in nature. Not reported in nature
4-Ethyl-2-hexyl-5-methyloxazole
Not reported in nature. Not reported in nature
4,5-Dimethyl-2-heptyloxazole
Not reported in nature. Not reported in nature
1-Amino-3-hydroxymethyl-5-methyl-adamantane
1-Amino-3-hydroxymethyl-5-methyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
3-Amino-1-hydroxy-5,7-dimethyl-adamantane
3-Amino-1-hydroxy-5,7-dimethyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
2-hydroxymexiletine
2-hydroxymexiletine is a metabolite of mexiletine. Mexiletine (sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form. (Wikipedia)
p-hydroxymexiletine
p-hydroxymexiletine is a metabolite of mexiletine. Mexiletine (sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form. (Wikipedia)
[3-(2-Aminopropyl)-6-methylidenecyclohexa-1,3-dien-1-yl]methanediol
1R-2-(2,6,6-trimethyl-4-oxo-2-cyclohexenyl)ethanamide|glaucenamide
1,2,3,5,6,8a-Hexahydro-alpha-propyl-8-indolizinemethanol
2,2-(p-Tolylazanediyl)diethanol
CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4749; ORIGINAL_PRECURSOR_SCAN_NO 4747 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4763; ORIGINAL_PRECURSOR_SCAN_NO 4760 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4776; ORIGINAL_PRECURSOR_SCAN_NO 4775 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4785; ORIGINAL_PRECURSOR_SCAN_NO 4783 CONFIDENCE standard compound; INTERNAL_ID 142; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4781; ORIGINAL_PRECURSOR_SCAN_NO 4778
(3R,5S,7aS)-3-methyl-5-pentylhexahydro-1H-pyrrolizine
(2S,6S)-2,6-DIISOPROPYL-2,3,5,6-TETRAHYDRO-1H-IMIDAZO[1,2-A]IMIDAZOLE
tert-butyl (1R,4S)-5-azabicyclo[2.2.1]hept-2-ene-5-carboxylate
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-1,2,3-TRIAZOLE
Hydrazinecarboxamide,2-[2-(1-cyclohexen-1-yl)-1-methylethylidene]-
ethyl 4-ethyl-3,5-dimethyl-1h-pyrrole-2-carboxylate
1-(2-THIENYLMETHYL)PIPERIDIN-4-YL]METHANOL HYDROCHLORIDE
(S)-1-((3AR,4R,6AS)-5-BENZYL-2,2-DIMETHYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-C]PYRROL-4-YL)-ETHANE-1,2-DIOL
8-amino-8-tricyclo[5,2,1,0(2,6)]decanecarboxylic acid
3,4-DIETHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER
Tricyclo[3.3.1.13,7]decane-1-MethanaMine, N-hydroxy-α-Methyl-
(-)-(1S,4R)-N-FMOC-4-AMINOCYCLOPENT-2-ENECARBOXYLICACID
tert-Butyl 2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate
N-(2-aminoethyl)ethane-1,2-diamine;2-(chloromethyl)oxirane
1-Amino-3-hydroxymethyl-5-methyl-adamantane
1-Amino-3-hydroxymethyl-5-methyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
Oxotremorine M
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
